Pharmaceutics · 2011 · 67 citations · 61 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryLead OptimizationEnzyme InhibitionPotency OptimizationSelectivity DesignSelectivity OptimizationActivity AnalysisBiological Evaluation ReportKinase InhibitorsProtein Kinase Inhibitors
Protein kinase D (PKD) belongs to a family of serine/threonine kinases that play an important role in basic cellular processes and are implicated in the pathogenesis of several diseases. Progress in our understanding of the biological functions of PKD has been limited due to the lack of a PKD-specific inhibitor. The benzoxoloazepinolone CID755673 was recently reported as the first potent and kinase-selective inhibitor for this enzyme. For structure-activity analysis purposes, a series of analogs was prepared and their in vitro inhibitory potency evaluated.
61
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
Bharat B. Aggarwal, Anjana Bhardwaj, Rishi S. Aggarwal et al. · PubMed · 2004 · 1.4K citations
Medicine, Oncology, Pharmacology +13
PKCu is a novel, atypical member of the protein kinase C family.
Franz‐Josef Johannes, J. Prestle, S. Eis et al. · Journal of Biological Chemistry · 1994 · 525 citations · Full text
Ángela M. Valverde, James Sinnett‐Smith, Johan Van Lint et al. · Proceedings of the National Academy of Sciences · 1994 · 410 citations